The landscape of dementia analysis has advanced drastically with the advent of sophisticated biomarkers, including amyloid PET scans, tau imaging, and blood-centered exams which will detect Alzheimer's pathology many years right before signs emerge. Though these technological developments depict remarkable development in being familiar with neurode